Apoena Biotech presents to the market its business unit for Cosmetic, Toiletry & Fragrance (CT&F), becoming the 1st Brazilian industry 100% dedicated to biotechnology for the sector. "It is a dynamic, innovative sector and in permanent search for new trends and increasingly sensitive to new technologies that allow the creation and development of effective products, aligned with responsible consumption and production, boosting the sustainable economy", comments Bruno Carillo, Managing Director of Apoena Biotech. "Our goal is to contribute to this movement in order to balance with authenticity purpose and profit", he adds.
Apoena derives from the tupi-guarani and means "the one who sees far". And with this premise, the company is committed to making biotechnology accessible to all, effectively acting on inclusive and sustainable solutions for the ecosystem.
´Greener´ than plant-based ingredients, the actives created and developed from biotechnology are also safer for consumers and the environment since -derived from microorganisms "of good"- they have low environmental impact and eliminate stages of monitoring and control of planting, harvesting and extraction.
"The control of biotech products is in bioreactors where they are produced, following parameters of pH, temperature, dissolved oxygen, among others, ensuring reproducibility, high quality standard and performance suitable for application as prebiotics, probiotics or postbiotics," explains Juliana Nakayama, Bioprocess Manager at Apoena Biotech.
The company's portfolio proposal is based a 100% on sustainable and efficacy proven ingredients. "Developing only natural products is far from solving the collective problem of environmental impact. Deforesting to plant and obtain the active is not a sustainable practice in its essence. Biotechnology is the best way to access nature, preserving the planet", adds Bruno.
As for efficacy, biotechnological ingredients can be compared to any other type of active and, in some cases, can even outperform them in performance. The reason for this phenomenon is that, from a biological standpoint the microorganisms are closer to humans than plants, and especially active ones of synthetic origin, so they produce substances more compatible with the body - the skin, for instance.
"With this, Apoena Biotech believes that biotechnology is already the future-leading technology for a new economic model that aims to balance the financial success, well-being of society and the planet. Future that happens now. Its interchangeability, competitive prices, effectiveness and low environmental impact at this time provoke a new wave of innovation that will change the way we idealize, develop, produce, formulate, apply, inform, educate and consume actives for CT&F, opening opportunities for industry and consumers in dialogues about Biotech Beauty", said Bruno.
About Apoena Biotech
The company was born in 2018 with the purpose of positively impacting sustainable development, supporting innovation projects through biotechnological ingredients. From its expertise in the agribusiness, the company launches in 2021 its business unit for the hygiene and personal care market, driving transparently and effectively the transformations for Beauty Biotechnology in the world, being the 1st Brazilian industry 100% dedicated to biotechnology for CT&F sector. https://en.apoenabiotech.com.br